2011-08-16 13:23:49 UTC

A Look at Therapies for <i>H. Pylori</i> Infection in Latin America

Aug. 19, 2011

Standard 14-day triple-drug therapy is preferable to five-day concomitant or 10-day sequential four-drug regimens as empiric therapy for Helicobacter pylori infection in diverse Latin American populations.

Evidence from Europe, Asia and North America suggests that standard three-drug regimens of a PPI plus amoxicillin and clarithromycin are significantly less effective for eradication of Helicobacter pylori (H. pylori) infection than are five-day concomitant and 10-day sequential four-drug regimens that include a nitroimidazole. These four-drug regimens also entail fewer antibiotic doses than do three-drug regimens, and thus could be suitable for eradication programs in low-resource settings. Few studies in Latin America have been done where the burden of H. pylori-associated diseases is high. Data published in the Lancet suggests that standard 14-day triple-drug therapy is preferable to five-day concomitant or 10-day sequential four-drug regimens as empiric therapy for H. pylori infection in diverse Latin American populations.

The Lancet 2011: 378(9790): 507-514

More on Helicobacter pylori Infection

Principles of GI for the NP and PA

Aug. 10, 2018

Hear from the experts as they provide you with critical updates on treating and managing patients with a variety of GI disorders.

Course for APPs benefits all experience levels

April 16, 2018

AGA's popular course for advanced practice providers will take place Aug. 10 through 12 in Chicago, Illinois.

APPs: Enhance your delivery of patient care

March 28, 2018

AGA's popular course for advanced practice providers will be held this summer in Chicago.